<PAGE> 1
------------------------------
OMB APPROVAL
------------------------------
OMB Number: 3235-0287
Expires: December 31, 2001
Estimated average burden
hours per response ....... 0.5
------------------------------
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
[_] Check this box if no longer subject of Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b)
(Print or Type Responses)
________________________________________________________________________________
1. Name and Address of Reporting Person*
Lamotte Andre
--------------------------------------------------------------------------------
(Last) (First) (Middle)
161 Worcester Rd.
--------------------------------------------------------------------------------
(Street)
Framingham, Massachusetts 01701
--------------------------------------------------------------------------------
(City) (State) (Zip)
________________________________________________________________________________
2. Issuer Name and Ticker or Trading Symbol
deCODE genetics, Inc. ("DCGN")
________________________________________________________________________________
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)
________________________________________________________________________________
4. Statement for Month/Year
July, 2000
________________________________________________________________________________
5. If Amendment, Date of Original (Month/Year)
================================================================================
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
[xx] Director [_] 10% Owner
[_] Officer (give title below) [_] Other (specify below) _
_______________________________________________________________________________
7. Individual or Joint/Group Filing (Check Applicable Line)
[xx] Form filed by One Reporting Person
[_ ] Form filed by More than One Reporting Person
________________________________________________________________________________
================================================================================
Table I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF,
OR BENEFICIALLY OWNED
================================================================================
<TABLE>
<CAPTION>
6.
4. 5. Owner-
Securities Acquired (A) or Amount of ship
3. Disposed of (D) Securities Form: 7.
Transaction (Instr. 3, 4, and 5) Beneficially Direct Nature of
2. Code ------------------------------- Owned at End (D) or Indirect
1. Transaction (Instr. 8) (A) of Month Indirect Beneficial
Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) (Month/Day/Year Code V (D) and 4) (Instr.4) (Instr. 4)
-----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Medical
Science
Partners
Common Stock 7/21/00 C 586,514 A 586,514 I(1) II, L.P.
-----------------------------------------------------------------------------------------------------------------------------------
Medical
Science II
Co-
Investment,
Common Stock 7/21/00 C 158,745 A 158,745 I(1) L.P.
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
* If the form is filed by more than one reporting person, see instruction
4(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
Potential persons who are to respond to the
collection of Information contained in this
form are not required to respond unless the
form displays a currently valid OMB control (Over)
number. SEC 1474 (3-99)
<PAGE> 2
FORM 4 (CONTINUED)
Table II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
(e.g., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
================================================================================
<TABLE>
<CAPTION>
10.
9. Owner-
Number ship
of Form
Deriv- of
Conver- 5. 7. ative Deriv- 11.
ion Number of Title and Amount Secur- ative Nature
or Derivative 6. of Underlying 8. ities Secur- of
1. Exer- 4. Securities Date Securities Price Bene- ity: In-
Title ise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct
of Deri- Price Trans- action or Disposed Expiration Date ------------------ Deriv- Owned (D) or Bene-
vate 0f action Code of(D) (Month/Day/Year) Amount ative at End In- ficial
Secur- Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner-
ity ative (Month/ 8) 4, and 5) Date Expira- Number ity Month (I) ship
(inst. Secur- Day/ ------- ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
3) ity Year) Code V (A) (D) cisable Date Title Shares 5) f 4) 4) 4)
----------------- ----------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Medical
Science
Partners
Series A Common II, L.P.
Preferred 7/21/00 C 586,514 Immed Stock 586,514 -0- I(1)
---------------- ------------------------------------------------------------------------------------------------------------------
Medical
Science
II Co-
Series A Common Invest-
Preferred 7/21/00 C 158,745 Immed Stock 158,745 -0- I(1) ment,
L.P.
-----------------------------------------------------------------------------------------------------------------------------------
Medical
Science
Warrant(2) Partners
Common II, L.P.
10/27/99 8/26/05 Stock 100,000 $1.00 100,00 I(1)
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
(1) The reporting person is the Managing General Partner of Medical Science
Partners II, L.P. and Medical Science II Co-Investment, L.P. The reporting
person disclaims beneficial ownership of the reported securities except to
the extent of his pecuniary interest therein.
(2) Upon closing of Issuer's public offering on July 21, 2000, the warrants
exercisable for Series A Preferred Stock became exercisable for Common
Stock.
/s/ Andre Lamotte 8/7/00
--------------------------------------------- -----------------------
**Signature of Reporting Person Date
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
Page 2
